Published in Biotech Business Week, January 29th, 2007
This trend article about Yale University, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Researchers detail in "Precursors of endometrial clear cell carcinoma," new data in endometrial cancer. "The recognition of morphologically identifiable lesions which may confer an increased risk for subsequent development of an invasive malignancy offers an opportunity to investigate and better understand the molecular-genetic etiopathogenesis of the well-developed tumor, and potentially, to administer a therapeutic intervention before its development....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.